Richard Walovitch, senior VP of clinical research for Acusphere (Watertown, Massachusetts), has resigned to pursue another opportunity. His resignation follows an 11-year career with Acusphere, in which he oversaw the company's clinical trials for its lead product candidate, Imagify (Perflubutane Polymer Microspheres) for Injectable Suspension, a cardiovascular drug for the detection of coronary artery disease. Acusphere is a specialty pharmaceutical company that makes new drugs and improved formulations of existing drugs using its microsphere technology.

Richard Price was named VP of payment and healthcare delivery policy for the Advanced Medical Technology Association (AdvaMed; Washington). Price most recently was legislative and health policy consultant with Hart Health Strategies. AdvaMed advocates for a legal, regulatory and economic environment that advances global healthcare by assuring worldwide patient access to the benefits of medical technology.

Kurt Schmidt was named CFO of Agendia (Huntington Beach, California). Most recently, Schmidt was a principal at a consulting firm he founded in 2002, providing high-level interim financial management and M&A services. Agendia makes molecular cancer diagnostics.

Joe Davis has joined Aspyra (Calabasas, California) as regional sales manager for the Southeastern U.S. region. Davis previously has been with various companies, including ScImage, Siemens Medical Solutions and Heartlab. Aspyra provides IT solutions to the healthcare industry.

• BioMedical Enterprises (BME; San Antonio) has named Kenneth Moch president/CEO. Casey Fox, PhD, BME's founder, will become chief technology officer. Moch has served as president of Euclidean Life Science Advisors since early 2008. BME makes memory metal implants used in orthopedic reconstructive surgery and fracture management.

Michael Ehrle was named VP of sales for Davis Vision's (Plainview, New York) Northern division. Prior to joining Davis Vision, Ehrle was national VP of specialty sales for UnitedHealth Group. Davis Vision is part of the HVHC group of companies which also includes Viva International Group and Eye Care Centers of America.

Jon DiVincenzo was named president of the bioscience division and member of the corporate executive committee of Millipore (Billerica, Massachusetts). Since joining Millipore in 1994, DiVincenzo has held a number of senior management positions within the bioscience division, most recently serving as VP of global sales and service and VP of marketing and R&D. Millipore makes bioscience research and biopharmaceutical manufacturing products.

George Bayz was named president/CEO of Optical Research Associates (ORA; Pasadena, California). Bayz succeeds former president/CEO Robert Hilbert, who passed away in December. Bayz previously was president/CEO of PeoplePoint Systems, and has served on the ORA board since 1999. ORA makes optical software.

Stephen Hanlon was named VP of R&D for OptiMedica (Santa Clara, California). Hanlon was previously VP of R&D for Boston Scientific's Neurovascular Division. OptiMedica is an ophthalmic device company.

• Patient Safety Technologies (Temecula, California) said that David Bruce was named president/CEO and will also join its board. Bill Adams, the company's former CEO, will remain involved with the company as a consultant. Most recently, Bruce was the CEO of EP MedSystems. Patient Safety Technologies makes the Safety-Sponge, a turnkey solution to prevent retained surgical sponges.

Stacy Feld was named a director of Physic Ventures (San Francisco). Previously, Feld was associate director of business development for Genentech. Physic Ventures is a venture capital firm dedicated to investing in consumer-driven health and sustainable living.